First report of an SH2D1A mutation associated with X-linked lymphoproliferative disease in Turkey
Open Access
- 26 January 2018
- journal article
- letter
- Published by Galenos Yayinevi in Turkish Journal of Hematology
- Vol. 35 (3) , 200-202
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Hematopoietic Stem Cell Transplant for Primary Immunodeficiency Diseases: A Single-Center Experience.Experimental and Clinical Transplantation, 2017
- XIAP deficiency in humans causes an X-linked lymphoproliferative syndromeNature, 2006
- Treatment of primary Epstein-Barr virus infection in patients with X-linked lymphoproliferative disease using B-cell-directed therapyBlood, 2004
- Correlation of mutations of the SH2D1A gene and epstein-barr virus infection with clinical phenotype and outcome in X-linked lymphoproliferative disease.2000
- Structural Basis for SH2D1A Mutations in X-Linked Lymphoproliferative DiseaseBiochemical and Biophysical Research Communications, 2000
- Host response to EBV infection in X-linked lymphoproliferative disease results from mutations in an SH2-domain encoding geneNature Genetics, 1998